• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
The returned device was not submerged in liquid.The device appeared to be dehydrated and exhibited a yellowish, translucent hue.Initial evaluation was conducted on the device as it was returned, seemingly dehydrated.The device feels firmer than a sterile, manufactured device but not as stiff as a fully dehydrated device.Visual examination revealed scuff marks on the side and the base of the implant, which may have been the result of friction against the bone cavity during the implant removal.Slanted indentations were found on the side of the dehydrated implant at a 10° measured angle from the implant base, possibly caused by device compression against the rim of the bone cavity.The angle of the indentation may be the result of non-perpendicular implantation in the metatarsal head.There appeared to be no guide pin holes in the device, suggesting implant removal by other means.The articulating surface had crevices that were smooth, segmented, and reflective.This wear pattern is not consistent with the scuffing seen in testing to simulate the equivalent of 5 years use.The device was left to rehydrate in 0.9% sterile saline for 24 hours.After rehydration, the device swelled slightly and exhibited a translucent, whitish hue.The scuff marks and wear patterns remained consistent after rehydration.After rehydration, both the height (9.5 mm) and the diameter (10.2 mm) of the device fell within the specifications of a sterile, manufactured 10mm cartiva device (9.0 mm 10.3 mm for height and 10.2 mm 11.0 mm for diameter.The mass of the device 0.8 was slightly lower than the mass data recorded from sterile, manufactured devices (0.85 - 0.93g), indicating measurable mass loss in the device, attributable to the areas of material loss characterized above.Based on the available visual and dimensional observations of the returned device, no definitive root cause could be identified regarding the reported event.On november 10st 2020 stryker trauma and extremities acquired cartiva, wright medical, tornier inc.And tornier (b)(4).An effort was made to align the acquired entity complaint files with stryker's policies and procedures.Stryker has performed retrospective review of complaints and the reportability decision was revised to report this incident under the mdr/vigilance process.
 
Event Description
It was reported that the patient underwent a surgical procedure.It was reported that the patient underwent a revision surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer (Section G)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer Contact
matthew parrish
1023 cherry rd
memphis, TN 38117
MDR Report Key13606099
MDR Text Key290531022
Report Number3009351194-2022-00067
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/06/2019
Initial Date FDA Received02/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-